slides · global inventory
Legend
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,863
Current window 10,321-10,350
Pages 463
Rows per page 30
Component
10,321-10,350 of 13,863
37
The slide uses a visual grid of models to represent different product lines (Tailoring, Smart Casual, Denim, Activewear) and maps them to brand sub-labels (Camel, Black, Orange, Collabs).Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Competition1 hit
16
The slide uses a table to compare patient demographics and clinical characteristics across different cancer types, specifically focusing on the sufficiency of the melanoma cohort for further development.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
27
The slide uses two line charts to demonstrate the superior durability of CD4 T cells in a serial killing assay.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
34
Uses a ridge plot (joyplot) to visualize distribution of PRAME expression across 7 cancer types.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
48
The chart uses a broken axis to show early time points and late-stage tumor volume divergence.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
34
The chart demonstrates deepening clinical responses over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
55
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
17
The chart illustrates the correlation between the peak of HBI0101 cells and the subsequent drop in dFLC, a marker for AL Amyloidosis.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
34
The chart demonstrates deepening clinical responses over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
61
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
35
The chart demonstrates deepening clinical response over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
64
The slide uses a bar-grouped chart format to highlight the efficacy gap between established treatments and placebo.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
10
The slide uses stacked bar charts to show revenue composition across four segments: Data/Patient Network, Women's health, Rare diseases/Other, and Oncology.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
The slide uses a mix of bar charts and a line-bar combo chart to track operational and financial performance metrics over four quarters.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
The slide uses a combination of logo-based segmentation and a grouped bar chart to illustrate portfolio composition and financial scale.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Solution1 hit
08
The slide highlights both established houses and recent acquisitions (Valentino, Lindberg, Maui Jim, Creed).Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Aha Moment1 hit
16
Data includes error bars representing standard error of the mean (S.E. of Mean) or 80% confidence intervals.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
37
Swimmer plot showing days on study for three patients, with corresponding CT scan imagery for one patient.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
05
The slide uses a timeline framework to demonstrate long-term IP protection.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
43
Data shows significant differences (****) between vehicle and CTI-1601 treated KO mice.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
44
The slide uses two line charts to demonstrate efficacy in two different cardiac metrics (Ejection Function and Fractional Shortening) over an 8-week period.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
09
The slide uses a grid-based layout to organize clinical trials by stage and therapeutic focus.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The chart uses a dual-axis approach to correlate margin expansion with ODR revenue growth.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
Includes YTD 2023 full year outlook projections.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
43
Includes a legend for blue dots indicating directors joined since 2018 and a footer note regarding age calculation date.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
20
The chart tracks individual patient outcomes over time, including treatment status, response type, and study exit reasons.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
29
The chart shows tumor volume over time, with the THIO group reaching 100% complete response (CR).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
38
The slide uses a growth curve background to imply value accumulation over time.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
43
The chart displays debt maturity by year, categorized by instrument type (SBIC debentures, Credit Facilities, and various Notes).Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
46
The chart highlights significant market events including the 2008 recessionary period and the COVID-19 pandemic.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit